Bonhoure E., Pchejetski D., Aouali N., Morjani H., Levade T., Kohama
T. and Cuvillier O. (2005) Overcoming MDR-associated chemoresistance in HL-60 acute myeloid leukemia cells by targeting
shingosine kinase-1. Leukemia 20, 95–102.
Campbell L., Abulrob A. N., Kandalaft L. E., Plummer S., Hollins A. J.,
Gibbs A. and Gumbleton M. (2003) Constitutive expression of p- glycoprotein in normal lung alveolar epithelium and functionality
in primary alveolar epithelial cultures. J. Pharmacol. Exp. Ther.
304, 441–452.
Chalfant C. E. and Spiegel S. (2005) Sphingosine 1-phosphate and
ceramide 1-phosphate: expanding roles in cell signaling. J. Cell
Sci. 118, 4605–4612.
Deininger M. H. and Schluesener H. J. (1999) Cyclooxygenases-1 and -2
are differentially localized to microglia and endothelium in rat EAE
and glioma. J. Neuroimmunol. 95, 202–208.
Demeule M., Labelle M., Regina A., Berthelet F. and Beliveau R. (2001)
Isolation of endothelial cells from brain, lung, and kidney:
expression of the multidrug resistance P-glycoprotein isoforms.
Biochem. Biophys. Res. Commun. 281, 827–834.
Devault A. and Gros P. (1990) Two members of the mouse mdr gene
family confer multidrug resistance with overlapping but distinct
drug specificities. Mol. Cell Biol. 10, 1652–1663.
French K. J., Schrecengost R. S., Lee B. D., Zhuang Y., Smith S. N., Eberly
J. L., Yun J. K. and Smith C. D. (2003) Discovery and evaluation of
inhibitors of human sphingosine kinase. Cancer Res. 63, 5962–5969.
Hayashi K., Pu H., Tian J., Andras I. E., Lee Y. W., Hennig B. and Toborek
M. (2005) HIV-Tat protein induces P-glycoprotein expression in
brain microvascular endothelial cells. J. Neurochem. 93, 1231–1241.
Henson J. W., Cordon-Cardo C. and Posner J. B. (1992) P-glycoprotein
expression in brain tumors. J. Neurooncol. 14, 37–43.
Jodoin J., Demeule M., Fenart L., Cecchelli R., Farmer S., Linton K. J.,
Higgins C. F. and Beliveau R. (2003) P-glycoprotein in blood-brain
barrier endothelial cells: interaction and oligomerization with
caveolins. J. Neurochem. 87, 1010–1023.
Liu F., Verin A. D., Wang P., Day R., Wersto R. P., Chrest F. J., English
D. K. and Garcia J. G. (2001) Differential regulation of sphingosine-1-phosphate- and VEGF-induced endothelial cell chemotaxis.
Involvement of G(ialpha2)-linked Rho kinase activity. Am. J.
Respir. Cell Mol. Biol. 24, 711–719.
Maceyka M., Payne S. G., Milstien S. and Spiegel S. (2002) Sphingosine
kinase, sphingosine-1-phosphate, and apoptosis. Biochim. Biophys.
Acta 1585, 193–201.
Maceyka M., Milstien S. and Spiegel S. (2005) Sphingosine kinases,
sphingosine-1-phosphate and sphingolipidomics. Prostaglandins
Other Lipid Mediat. 77, 15–22.
Monnier Y., Zaric J. and Ruegg C. (2005) Inhibition of angiogenesis by
non-steroidal anti-inflammatory drugs: from the bench to the
bedside and back. Curr. Drug Targets Inflamm. Allergy 4, 31–38.
Ozben T. (2006) Mechanisms and strategies to overcome multiple drug
resistance in cancer. FEBS Lett. 580, 2903–2909.
Patel V. A., Dunn M. J. and Sorokin A. (2002) Regulation of MDR-1 (P- glycoprotein) by cyclooxygenase-2. J. Biol. Chem. 277, 38 915–
38 920.
Pchejetski D., Golzio M., Bonhoure E. et al. (2005) Sphingosine kinase- 1 as a chemotherapy sensor in prostate adenocarcinoma cell and
mouse models. Cancer Res 65, 11 667–11 675.
